ORSI, Carlotta Francesca
 Distribuzione geografica
Continente #
EU - Europa 17.284
NA - Nord America 3.726
AS - Asia 923
SA - Sud America 26
OC - Oceania 10
AF - Africa 5
Continente sconosciuto - Info sul continente non disponibili 5
Totale 21.979
Nazione #
IT - Italia 14.903
US - Stati Uniti d'America 3.703
GB - Regno Unito 872
FR - Francia 486
CN - Cina 361
SE - Svezia 272
DE - Germania 267
SG - Singapore 230
UA - Ucraina 149
HK - Hong Kong 110
TR - Turchia 96
FI - Finlandia 80
BG - Bulgaria 44
CH - Svizzera 35
PL - Polonia 31
IN - India 29
RU - Federazione Russa 26
IR - Iran 24
RO - Romania 23
KR - Corea 22
NL - Olanda 21
ES - Italia 17
BR - Brasile 16
CA - Canada 16
BE - Belgio 11
AU - Australia 10
DK - Danimarca 9
TH - Thailandia 7
CZ - Repubblica Ceca 6
ID - Indonesia 6
AR - Argentina 5
JP - Giappone 5
MY - Malesia 5
NO - Norvegia 5
PK - Pakistan 5
AT - Austria 4
LT - Lituania 4
PE - Perù 4
SM - San Marino 4
VN - Vietnam 4
AE - Emirati Arabi Uniti 3
BD - Bangladesh 3
EU - Europa 3
HR - Croazia 3
IE - Irlanda 3
MX - Messico 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AN - Antille olandesi 2
HU - Ungheria 2
IL - Israele 2
LB - Libano 2
SI - Slovenia 2
TW - Taiwan 2
ZA - Sudafrica 2
AM - Armenia 1
AZ - Azerbaigian 1
BZ - Belize 1
GR - Grecia 1
IQ - Iraq 1
JO - Giordania 1
KE - Kenya 1
KG - Kirghizistan 1
KH - Cambogia 1
LV - Lettonia 1
MA - Marocco 1
MK - Macedonia 1
NG - Nigeria 1
PA - Panama 1
PH - Filippine 1
PT - Portogallo 1
RS - Serbia 1
VE - Venezuela 1
Totale 21.979
Città #
Southend 698
Milan 621
Rome 557
Bologna 426
Chandler 380
Fairfield 345
Torino 295
Woodbridge 276
Ashburn 257
Jacksonville 255
Florence 234
Santa Clara 223
Houston 177
Singapore 177
Ann Arbor 174
Dearborn 174
Nyköping 152
Catania 142
Modena 137
Wilmington 135
Genova 128
Padova 120
Seattle 120
Hong Kong 108
Castelnuovo Rangone 104
Venezia 102
Verona 99
Cambridge 93
Turin 93
Napoli 86
Beijing 81
Pisa 78
Reggio Nell'emilia 72
Bari 70
Palermo 67
Trento 65
New York 61
Naples 60
Bolzano 52
Dallas 51
Piemonte 50
Trieste 49
Genoa 47
Princeton 47
Udine 47
Oggiono 45
Izmir 44
Eugene 42
Monza 42
Sofia 42
Bremen 41
Helsinki 41
Messina 37
Parma 35
Pavia 33
Rio Saliceto 33
San Diego 30
Bergamo 29
Prato 28
Cagliari 27
Dolo 27
Ferrara 27
Brescia 26
Des Moines 26
Mountain View 26
Shanghai 25
Wuhan 25
Cornigliano 24
Redwood City 23
Venice 22
Boardman 21
Reggio Emilia 21
Sassari 21
Ferentino 20
Malo 20
Vicenza 20
Perugia 19
Piacenza 19
Novara 18
Falls Church 17
Paris 17
Rimini 17
Cecina 16
Jesi 16
Foggia 15
Fremont 15
La Spezia 15
Livorno 15
London 15
Treviso 15
Como 14
Desio 14
Lissone 14
Manchester 14
Ravenna 14
Guangzhou 13
Siena 13
Toronto 13
Augusta 12
Massa 12
Totale 9.070
Nome #
RICERCA DI MARCATORI PER LA DIAGNOSI DI INFEZIONE FUNGINA INVASIVAE (IFI) MEDIANTE APPROCCIO DIAGNOSTICO COMBINATO 15.028
RICERCA DI DNA DI Pneumocystis jirovecii NEL LIQUIDO DI LAVAGGIO BRONCOALVEOLARE MEDIANTE IL TEST IN REAL-TIME PCR MYCASSAY™ PNEUMOCYSTIS 707
In vitro effects of commercial mouthwashes on several virulence traits of Candida albicans, viridans streptococci and Enterococcus faecalis colonizing the oral cavity. 250
EFFETTI DELLA TOSSINA DI ORIGINE ALGALE YESSOTOSSINA (YTX) SULLA ATTIVITA’ DEL MACROFAGO 248
IL GENOTIPO HWP1 DI CANDIDA ALBICANS INFLUENZA LA SUSCETTIBILITÀ FUNGINA ALLE CELLULE MICROGLIALI, MA NON LA PRODUZIONE DI BIOFILM 246
The human immunodeficiency virus (HIV) protease inhibitor indinavir directly affects the opportunistic fungal pathogen Cryptococcus neoformans 239
Yessotoxin inhibits phagocytic activity of macrophages. 223
Evaluation of serum (1 → 3)-β-D-glucan clinical performance: kinetic assessment, comparison with galactomannan and evaluation of confounding factors 216
Clinical performance of a commercial real-time PCR assay for Aspergillus DNA detection in serum samples from high-risk patients: comparison with a galactomannan enzyme immunoassay 209
The encapsulated strain TIGR4 of Streptococcus pneumoniae is phagocytosed but is resistant to intracellular killing by mouse microglia 207
Herpes simplex virus-1 entrapped in Candida albicans biofilm displays decreased sensitivity to antivirals. 201
Impact of Candida albicans hyphal wall protein 1 (HWP1) genotype on biofilm production and fungal susceptibility to microglial cells 200
Detection of Pneumocystis jirovecii and Aspergillus spp. DNa in bronchoalveolar lavage fluids by commercial real-time PCr assays: comparison with conventional diagnostic tests 200
A protein microarray immunoassay for the serological evaluation of the antibody response in vertically transmitted infections. 200
Antiviral activity of Hyaluronic Acid 191
Identification and characterization of an aspartyl protease from Cryptococcus neoformans 186
Gene expression profiling of monocytes displaying herpes simplex virus 1 induced dysregulation of antifungal defences 184
Candida albicans biofilm can retain and release Human Herpes simplex virus type 1 in vitro 179
Herpes simplex virus type 1 dysregulates anti-fungal defenses preventing monocyte activation and downregulating toll-like receptor-2 175
Candida metapsilosis as the least virulent member of the 'C. parapsilosis' complex 174
Adaptive response of microglial cells to in vitro infection by Candida albicans isolates with different genomic backgrounds 171
CANDIDA ALBICANS HYPHAL DEVELOPMENT AND BIOFILM FORMATION/PERSISTENCE ARE DIFFERENTIALLY AFFECTED BY MOUTHWASHES DEPENDING UPON THEIR COMPOSITION. 164
Effects of different mouthwashes on Candida albicans adhesion, susceptibility to phagocytic cells and capacity to elicit pro-inflammatory cytokine response 160
Candida albicans survival, growth and biofilm formation are differently affected by mouthwashes: an in vitro study 159
In vitro interactions between viruses and Candida biofilm. 153
Gene expression profiling on monocytes displaying Herpes Simplex virus 1-induced dysregulation of antifungal defences. 148
Diagnostic utility of a microarray based on 11 proteins of Candida albicans for the diagnosis of invasive candidiasis 137
Human pathogenic viruses are retained in and released by Candida albicans biofilm in vitro 137
PROFILO DELLA RISPOSTA ANTICORPALE A CANDIDA ALBICANS IN DIFFERENTI CATEGORIE DI PAZIENTI A RISCHIO DI INFEZIONI FUNGINE INVASIVE 136
The ABC transporter-encoding gene AFR1 affects the resistance of Cryptococcus neoformans to microglia-mediated antifungal activity by delaying phagosomal maturation. 133
The protein “mycoarray”: a novel serological assay for the laboratory diagnosis of primitive endemic mycoses 131
POLIMORFISMO DEL GENE HWP1 IN CANDIDA ALBICANS: POSSIBILE RUOLO NELLA PRODUZIONE DI BIOFILM E NELL’INTERAZIONE CON IL MACROFAGO 129
Beretti F., Cermelli C., Cenacchi V., Orsi C., Blasi E., Portolani M. 126
Caratterizzazione immunobiologica di nuovi antigeni proteici di Streptococcus pneumoniae selezionati mediante "phage display" 123
Inhibitory effects of different lactobacilli on Candida albicans hyphal formation and biofilm development. 123
Il gene AFR1 di Cryptococcus neoformans codificante per un trasportatore ABC, altera la resistenza del patogeno alla microglia: ritardo nella maturazione dei fagosomi. 122
Risposta differenziale della cellula di microglia ad isolati clinici di Candida albicans con differente genotipo 110
Human herpesvirus-6 dysregulates monocyte-ediated anticryptococcal defences. 110
HSV-1 induces dysregulation of monocyte anticandida functions 105
Growth of Epstein-Barr Virus on monocytes and its effects on immune functions. 102
Pneumocystis jirovecii genotyping: experience in a tertiary-care hospital in Northern Italy 95
Initial geno-phenotypic characterization of colon mycobiota from healthy donors 18
Indagini multidirezionali nella diagnosi di infezione fungina invasiva: ricerca di beta-glucano e rilevazione di profili anticorpali specifici 18
Effectiveness of the antibody-derived killer peptide on Candida albicans biofilm 16
Totale 22.289
Categoria #
all - tutte 42.171
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 42.171


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20203.389 0 0 0 0 516 438 514 376 430 414 385 316
2020/20212.860 315 218 261 269 355 249 187 219 180 210 225 172
2021/20221.902 147 122 125 144 135 145 121 156 171 138 269 229
2022/20233.063 265 234 225 259 289 307 201 281 305 149 262 286
2023/20241.951 213 209 190 162 251 136 191 194 62 98 105 140
2024/2025831 122 112 109 202 286 0 0 0 0 0 0 0
Totale 22.289